Table 4 Distribution of SNP array results within groups of different classifications
Categories | Clinically significant findings (P/LP) | VOUS | LB | Normal |
|---|---|---|---|---|
Gestational age | ||||
 ≤ 24 weeks (n = 93) | 6, 6.5% | 3, 3.2% | 2, 2.2% | 82, 88.2% |
25–28 weeks (n = 80) | 1, 1.3% | 2, 2.5% | 1, 1.3% | 76, 95.0% |
29–32 weeks (n = 81) | 4, 4.9% | 1, 1.2% | 0, 0.0% | 76, 93.8% |
 > 32 weeks (n = 5) | 0, 0.0% | 0, 0.0% | 0, 0.0% | 5, 100% |
Ultrasound findings | ||||
Isolated FGR (n = 181) | 4, 2.2% | 1, 0.6% | 5, 2.8% | 171, 94.5% |
FGR with soft markers (n = 63) | 6, 9.5% | 2, 3.2% | 0, 0.0% | 55, 87.3% |
FGR with nonstructural abnormalities (n = 15) | 1, 6.7% | 0, 0.0% | 1, 6.7% | 13, 86.7% |
Serological screening | ||||
High risk (n = 25) | 3, 12.0% | 1, 4.0% | 1, 4.0% | 20, 80.0% |
Low risk (n = 82) | 0, 0.0% | 2, 2.4% | 3, 3.7% | 77, 93.9% |